|Articles|October 2, 2018
Release of ADDPLAN neo Announced by ICON
Advertisement
ICON, a provider of drug development services, announced the release of ADDPLAN® neo, providing a technology platform for design, simulation, and analysis of adaptive clinical trials. The new release combines three modules, ADDPLAN® BASE, ADDPLAN® MC, and ADDPLAN® DF to become integrated under one robust framework.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5